| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTIC | common stock | Options Exercise | $23,971 | +28,500 | $0.8411* | 28,500 | 08 Nov 2022 | Direct | ||
| transaction | CTIC | common stock | Options Exercise | $63,000 | +63,000 | +221% | $1.00* | 91,500 | 08 Nov 2022 | Direct | |
| transaction | CTIC | common stock | Sale | $276,781 | -50,058 | -55% | $5.53 | 41,442 | 08 Nov 2022 | Direct | F1, F2 |
| transaction | CTIC | common stock | Sale | $208,578 | -36,942 | -89% | $5.65 | 4,500 | 08 Nov 2022 | Direct | F1, F3 |
| transaction | CTIC | common stock | Sale | $25,660 | -4,500 | -100% | $5.70 | 0 | 08 Nov 2022 | Direct | F1, F4 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CTIC | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -28,500 | -100% | $0.000000* | 0 | 08 Nov 2022 | Common Stock | 28,500 | $0.8411 | Direct | F5 |
| transaction | CTIC | Non-Qualified Stock Option (right to buy) | Options Exercise | $0 | -63,000 | -50% | $0.000000 | 63,000 | 08 Nov 2022 | Common Stock | 63,000 | $1.00 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | This sale was effected pursuant to a 10b5-1 sales plan adopted by the Reporting Person. |
| F2 | Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.50 to $ 5.59. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F3 | Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.60 to $ 5.695. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F4 | Reflects sales of common stock executed in multiple transactions at prices ranging from $ 5.70 to $ 5.72. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. |
| F5 | The shares underlying the option were fully vested on May 16, 2020, the date that is twelve months after the date of grant. |
| F6 | The shares underlying the option were fully vested on March 11, 2021, the date that is twelve months after the date of grant. |